Proteomic and Functional Analyses Reveal the Potential Involvement of Endoplasmic Reticulum Stress and α-CP1 in the Anticancer Activities of Oridonin in HepG2 Cells

Abstract

Oridonin has been shown to exhibit therapeutic effects against hepatocellular carcinoma (HCC) in vitro and in vivo. This study aimed to identify the anti-HCC mechanisms of oridonin in HepG2 cells using proteomic and functional analyses. MTT assay showed that oridonin treatment for 24 hours dose-dependently inhibited cell growth with an IC₅₀ value of 40.4 μM. Treatment with 40 μM oridonin for 24 hours induced apoptosis determined by nuclear morphologic changes of DAPI-stained cells and flow cytometric analysis of annexin V-FITC/PI-stained cells, which was accompanied by Grp78 upregulation and α-CP1 downregulation identified by proteomic analysis. Immunoblot analysis for the endoplasmic reticulum (ER) stress— related proteins demonstrated that the expression levels of phosphorylated PERK (p-PERK) and CHOP were increased, whereas PERK, ATF-6, and IRE-1 expression levels were decreased. Knockdown of α-CP1 expression with siRNA significantly increased cell death and apoptosis in control and oridonin-treated HepG2 cells. Together, these data provide proteomic and functional evidence for the potential involvement of ER stress and α-CP1 in the antiproliferative and apoptotic activities of oridonin in HepG2 cells, which shed new light on the action mechanisms of oridonin in HCC management.

Keywords

α-CP1 apoptosis ER stress Grp78 oridonin proteomics

References

Bai N. , He K. , Zhou Z. , et al. Ent-kaurane diterpenoids from Rabdosia rubescens and their cytotoxic effects on human cancer cell lines. Planta Med. 2010;76:140-145.

Wang SF , Lu QL Modern research survey on Rabdosia rubescens. Guangzhou Yi Yao. 2008;39:46-48.

Ikezoe T. , Chen SS , Tong XJ , Heber D. , Taguchi H. , Koeffler HP Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells. Int J Oncol. 2003;23:1187-1193.

Cui Q. , Tashiro S. , Onodera S. , Minami M. , Ikejima T. Oridonin induced autophagy in human cervical carcinoma HeLa cells through Ras, JNK, and P38 regulation. J Pharmacol Sci. 2007; 105:317-325.

Han J. , Ye M. , Qiao X. , Wu WY , Qu GQ , Guo DA Induction of apoptosis and G2/M cell cycle arrest by oridonin in human gastric cancer BGC-823 cells. Zhongguo Yao Xue. 2007 ;16:307-314.

Zhou GB , Kang H. , Wang L. , et al. Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo. Blood. 2007;109:3441-3450.

Kang N. , Zhang JH , Qiu F. , et al. Induction of G(2)/M phase arrest and apoptosis by oridonin in human laryngeal carcinoma cells. J Nat Prod. 2010;73:1058-1063.

Ren KK , Wang HZ , Xie LP , et al. The effects of oridonin on cell growth, cell cycle, cell migration and differentiation in melanoma cells. J Ethnopharmacol. 2006;103:176-180.

Zhang JF , Chen GH , Lu MQ , Liu JJ Antiproliferation efects of oridonin on hepatocellular carcinoma BEL-7402 cells and its mechanism. Chin Tradit Patent Med. 2006;28: 1325-1329.

10.

Huang J. , Wu L. , Tashiro S. , Onodera S. , Ikejima T. Reactive oxygen species mediate oridonin-induced HepG2 apoptosis through p53, MAPK, and mitochondrial signaling pathways. J Pharmacol Sci . 2008;107:370-379.

11.

Wu J. , Yuan SJ , Yang DX , Tian ZY Oridonin inhibited the growth of BGC823 cells aim the expression of MMP-2 MMP-9. Pharm J Chin PLA. 2007;23:344-347.

12.

Wang ZN , Wo XD , Zhou YL Molecule mechanisms of Oridonin on tumors chemoprevention and therapy. Zhong guo yi yao dao bao. 2008;5(28):14-16.

13.

Lei T. , He QY , Cai Z. , et al. Proteomic analysis of chromium cytotoxicity in cultured rat lung epithelial cells. Proteomics. 2008;8:2420-2429.

14.

Wu H. , Pan CL , Yao YC , Chang SS , Li SL , Wu TF Proteomic analysis of the effect of Antrodia camphorata extract on human lung cancer A549 cell. Proteomics. 2006;6: 826-835.

15.

Schroder M. , Kaufman RJ ER stress and the unfolded protein response . Mutat Res. 2005;569:29-63.

16.

Zhang K. , Kaufman RJ The unfolded protein response: a stress signaling pathway critical for health and disease. Neurology. 2006;66(2Suppl1):S102-S109.

17.

Gorlach A. , Klappa P. , Kietzmann T. The endoplasmic reticulum: folding, calcium homeostasis, signaling, and redox control. Antioxid Redox Signal. 2006;8:1391-1418.

18.

Araki E. , Oyadomari S. , Mori M. Endoplasmic reticulum stress and diabetes mellitus. Intern Med. 2003;42:7-14.

19.

Toth A. , Nickson P. , Mandl A. , Bannister ML , Toth K. , Erhardt P. Endoplasmic reticulum stress as a novel therapeutic target in heart diseases . Cardiovasc Hematol Disord Drug Targets. 2007;7:205-218.

20.

Oyadomari S. , Araki E. , Mori M. Endoplasmic reticulum stress-mediated apoptosis in pancreatic beta-cells. Apoptosis. 2002;7:335-345.

21.

Marciniak SJ , Ron D. Endoplasmic reticulum stress signaling in disease. Physiol Rev. 2006;86:1133-1149.

22.

Carpenter B. , MacKay C. , Alnabulsi A. , et al. The roles of heterogeneous nuclear ribonucleoproteins in tumour development and progression. Biochim Biophys Acta. 2006;1765:85-100

23.

.. Xu Y. , Wang YH , Gao JD , et al. Suppression of c-myc expression by interference RNA in HepG2 hepatocellular carcinoma cells . Zhonghua Zhong Liu Za Zhi. 2004;26:458-460.

24.

Cato AC , Mink S. BAG-1 family of cochaperones in the modulation of nuclear receptor action . J Steroid Biochem Mol Biol. 2001;78:379-388.

25.

Krajewski S. , Krajewska M. , Turner BC , et al. Prognostic significance of apoptosis regulators in breast cancer. Endocr Relat Cancer. 1999;6:29-40.

26.

Gaddameedhi S. , Chatterjee S. Association between the unfolded protein response, induced by 2-deoxyglucose, and hypersensitivity to cisplatin: a mechanistic study employing molecular genomics. J Cancer Res Ther. 2009;5(Suppl 1): S61-S66.

27.

Chandrika BB , Maney SK , Lekshmi SU , et al. Bax deficiency mediated drug resistance can be reversed by endoplasmic reticulum stress induced death signaling. Biochem Pharmacol. 2010;79:1589-1599.